Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for cbdMD, Inc. (YCBD:NYSE), powered by AI.
cbdMD, Inc. is currently trading at $0.69. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for cbdMD, Inc. on Alpha Lenz.
cbdMD, Inc.'s P/E ratio is -1.4.
“cbdMD, Inc. trades at a P/E of -1.4 (undervalued) with modest ROE of -44.4%.”
Ask for details →cbdMD, Inc. is a prominent player in the cannabidiol (CBD) industry, focusing on the production and distribution of high-quality, hemp-derived CBD products. The company's main purpose is to develop a diverse range of wellness products, which include tinctures, gummies, topicals, and bath bombs, designed to enhance personal health and wellness. cbdMD stands out in the competitive CBD market by prioritizing quality and purity, utilizing industry-leading manufacturing processes and rigorous third-party testing to ensure its products are THC-free and meet stringent standards. With its headquarters in Charlotte, North Carolina, cbdMD has positioned itself as a key contributor to the rapidly growing cannabis and wellness sectors. It serves both retail and wholesale clients across various channels, including e-commerce platforms, specialty health stores, and professional sports organizations. By leveraging strategic marketing and product innovation, cbdMD, Inc. continues to play a critical role in educating consumers and expanding the acceptance of CBD as a viable health supplement.
“cbdMD, Inc. trades at a P/E of -1.4 (undervalued) with modest ROE of -44.4%.”
Ask for details →cbdMD, Inc. (ticker: YCBD) is a company listed on NYSE in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 42 employees. Market cap is $3M.
The current price is $0.686 with a P/E ratio of -1.35x and P/B of 0.38x.
ROE is -44.42% and operating margin is -11.27%. Annual revenue is $19M.